Last reviewed · How we verify
Renacidin (MAGNESIUM CARBONATE)
At a glance
| Generic name | MAGNESIUM CARBONATE |
|---|---|
| Sponsor | United Guardian |
| Drug class | Vitamin C [EPC] |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | FDA-approved |
| First approval | 1990 |
Approved indications
- Calcium Phosphate Renal Calculi
- Constipation
- Gastric Hypersecretory Conditions
- Gastroesophageal reflux disease
- Heartburn
- Hiatal Hernia with Reflux Esophagitis
- Hypomagnesemia
- Incomplete passage of stool
- Indigestion
- Peptic ulcer
- Struvite Renal Calculi
Common side effects
Drug interactions
- tetracycline
- zalcitabine
Key clinical trials
- PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition (PHASE2)
- Quality of Life in Diarrhea-predominant Irritable Bowel Syndrome Taking GABA (NA)
- Study Assessing CLENPIQ as Bowel Preparation for Pediatric Colonoscopy (PHASE1,PHASE2)
- Clinical Study to Assess Safety, Effectiveness and In-Use Tolerability of Saffron Extract Capsules for Improving Skin Health and Reducing Signs of Aging on Healthy Adult Male and Female Subjects. (NA)
- Efficacy Study of a Food Supplement With Myo-inositol, N-Acetyl-Cystein, Zinc and Vitamins on Sperm DNA Fragmentation (NA)
- Efect Supplementation Vitamin D in Diabetes Mellitus Type 2 (NA)
- Open-Label Placebo Treatment of Women With Premenstrual Syndrome (NA)
- Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Chronic Non-cancer Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Renacidin CI brief — competitive landscape report
- Renacidin updates RSS · CI watch RSS
- United Guardian portfolio CI